SODIUM PICOSULPHATE AND MAGNESIUM CITRATE VERSUS POLYETHYLENE GLYCOLE (PEG) AS EVACUATING TREATMENT PRIOR TO COLONOSCOPY: PHASE IV RANDOMIZED TRIAL - ND

• Conditions: ?Subjects who are candidate to undergo colonoscopy:?Diagnosis ?Screening?Follow-up after previous polipectomy; MedDRA version: 13.1Level: PTClassification code 10010011Term: Colonoscopy normalSystem Organ Class: 10022891 - Investigations

• Registration Number: EUCTR2011-000587-10-IT
• Lead Sponsor: ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-05-12
• Last Update Posted: 3 April 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

?Subjects who are candidate to undergo colonoscopy:
?Diagnosis
?Screening
?Follow-up after previous polipectomy
?Informed consent
?Age > 18 years
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

?Previous colonic resection
?Severe inflammatory bowel disease (IBD)
?Renal failure
?Heart failure (NYHA class III or IV)
?Liver failure (Child-Pugh B or C)
?Severe dehydration
?Lithium assumption
?Pregnancy
?Known contra-indications to bowel preparation (e.g. hypermagnesemia, rabdomiolisis)
?Known contraindications to colonoscopy

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified